Unfortunately, yes.: I'm not a pediatrician, but Synagis (palivizumab) is a monoclonal antibody (mAb) used to prevent respiratory syncytial virus (RSV) infections, recommended for infants @ high-risk because of med problems such as prematurity & congenital heart disease. (I assume ur baby is high-risk). As mAbs wear off after a few wks, if RSV is present year-round, then ur baby needs routine mAb injx until s/he is no longer @ risk
Answered 9/3/2014
3.7k views
It depends: Your ex-premie Synagis (palivizumab) schedule depends on many factors. Intants with bronchopulmonary dysplasia or congenital heart disease will have very specific requirements. Because Florida is semi-tropical, many respiratory illnesses such as RSV and influenza have year round prevalence. Your pediatric pulmonologist should be well versed and reliable on current recommendations for your state.
Answered 9/3/2014
3.7k views
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question